CFDE Data Portal | Search LINC02864

	Label	Description
	LINC02864 Gene (Entity type)	ENSG00000263711 - long intergenic non-protein coding RNA 2864
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 amiloride 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149768 hypoxanthine 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146612 amiodarone 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02864

ENSG00000263711 - long intergenic non-protein coding RNA 2864

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 7 human dn

A Gene Set from LINCS

GSE95077 amiloride 1 v 0 human up

A Gene Set from LINCS

GSE149768 hypoxanthine 3 v 1 human up

A Gene Set from LINCS

GSE216043 cisplatin 3 v 9 human dn

A Gene Set from LINCS

GSE146612 amiodarone 2 v 3 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 1 human dn

A Gene Set from LINCS

GSE239844 crizotinib 8 v 9 human dn

A Gene Set from LINCS

GSE108464 AZ-628 11 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.